glp-1 shortage fda Eli Lilly's Mounjaro, Zepbound removed from FDA's list FDA Ban on Compounded GLP-1

Why Youll Love It

Could losing weight impair physical function in certain patient populations

After supplementation, there was a more marked increase in IGF-I levels, and notably, the IGF-II peak was found earlier compared to the placebo, at the same time as IGF-I

The complexity of hEDS, involving multiple bodily systems and diverse manifestations such as chronic pain, dysautonomia, and gastrointestinal dysfunction, further complicates timely diagnosis [95]

A study conducted in March 2025 involving 350,000 patients found that two years of Ozempic use more than doubled the risk of developing the condition compared to alternative diabetes treatments